Fresenius Medical Care | FME - Sales Revenues



Fresenius Medical Care reported EUR4.79B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Akzo Nobel EUR 2.63B 20M Jun/2025
Alcon AG USD 2.58B 130M Jun/2025
AstraZeneca USD 14.46B 867M Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Beiersdorf EUR 2.5B 190M Jun/2025
DaVita Healthcare Partners USD 3.38B 160M Jun/2025
Demant DKK 5.63B 10M Jun/2025
E.ON EUR 16.34B 8.88B Jun/2025
Essilor EUR 14.02B 7.17B Jun/2025
Fresenius EUR 5.58B 70M Jun/2025
Fresenius Medical Care EUR 4.79B 90M Jun/2025
Genmab DKK 5.86B 580M Jun/2025
Getinge SEK 11.07B 3.2B Dec/2024
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 7.99B 470M Jun/2025
GN Store Nord DKK 4.16B 170M Jun/2025
GRIFOLS EUR 1.89B 100M Jun/2025
Hikma Pharmaceutical USD 1.59B 18M Dec/2024
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 4.43B 850M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Philips EUR 4.34B 241M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
RWE EUR 3.72B 2.72B Jun/2025
Sanofi EUR 9.99B 90M Jun/2025
SAP EUR 9.03B 20M Jun/2025
Smith & Nephew USD 1.55B 140M Jun/2025